Indoco Remedies (NSE:INDOCO) Total Liabilities: ₹16,612 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDOCO Indoco Remedies Ltd NSE:INDOCO
68 GF Score
Price ₹251.91
GF Value ₹362.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Indoco Remedies Total Liabilities?

Indoco Remedies NSE:INDOCO +0.94% 68 Total Liabilities is ₹16,612 Mil as of Mar. 2026. GuruFocus rates NSE:INDOCO with a GF Score™ of 68/100 and a GF Value™ of ₹362.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Indoco Remedies's Total Liabilities for the quarter that ended in Mar. 2026 was ₹16,612 Mil.

Indoco Remedies's quarterly Total Liabilities declined from Sep. 2025 (₹15,337.10 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹16,611.60 Mil).

Indoco Remedies's annual Total Liabilities increased from Mar. 2024 (₹10,342.32 Mil) to Mar. 2025 (₹14,115.35 Mil) and increased from Mar. 2025 (₹14,115.35 Mil) to Mar. 2026 (₹16,611.60 Mil).

Indoco Remedies Total Liabilities Historical Data

* Premium members only.

The historical data trend for Indoco Remedies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies Total Liabilities Chart

Indoco Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,814.52 6,299.47 10,342.32 14,115.35 16,611.60

Indoco Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,115.35 0.00 15,337.10 0.00 16,611.60
NSE:INDOCO
68GF Score
Indoco Remedies Ltd NSE:INDOCO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indoco Remedies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Indoco Remedies's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10525.4+(5583.6+146.1
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+356.5+0)
=16,612

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=25932.7-9321.1
=16,612

Indoco Remedies's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10525.4+(5583.6+146.1
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+356.5+0)
=16,612

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=25932.7-9321.1
=16,612

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹16,612 Mil mean?
Indoco Remedies (NSE:INDOCO) has a Total Liabilities of ₹16,612 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Indoco Remedies and its competitors.
Is Indoco Remedies' Total Liabilities too high?
Indoco Remedies' current Total Liabilities is ₹16,612 Mil. Overall, Indoco Remedies has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' Total Liabilities compare to ZTS and UTHR?
Indoco Remedies' Total Liabilities of ₹16,612 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Indoco Remedies and its competitors. Indoco Remedies's current Total Liabilities is ₹16,612 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹362.05, compared to a current price of ₹251.91 — trading 30.4% below its estimated fair value. The current Total Liabilities is ₹16,612 Mil. Indoco Remedies' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current Total Liabilities is ₹16,612 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued. The current stock price of ₹251.91 is trading 30.4% below its estimated GF Value™ of ₹362.05. GuruFocus considers Indoco Remedies to be Possible Value Trap.

Key valuation signals for NSE:INDOCO:

  • Total Liabilities: ₹16,612 Mil
  • GF Value™: ₹362.05 vs. price of ₹251.91 (30.4% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indoco Remedies Business Description

Other Exchanges 532612:India
Address 166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
68GF Score

Get the complete analysis for NSE:INDOCO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹251.91
Price
₹362.05
GF Value